Literature DB >> 22202458

The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

Atsushi Nishida1, Cindy W Lau, Mei Zhang, Akira Andoh, Hai Ning Shi, Emiko Mizoguchi, Atsushi Mizoguchi.   

Abstract

BACKGROUND & AIMS: T helper (Th) 17 cells produce the effector cytokine interleukin (IL)-17, along with IL-22, which stimulates colonic epithelial cells to produce a membrane-bound mucin, Muc1. Muc1 is a component of the colonic mucus, which functions as a lubricant and a physiologic barrier between luminal contents and mucosal surface. The gene MUC1 has been associated with susceptibility to inflammatory bowel disease; we investigated the role of Muc1 in development of colitis in mice.
METHODS: Muc1 and RAG1 were disrupted in mice (Muc/RAG double knockout mice); Th1-mediated colitis was induced by intravenous injection of CD4(+)CD45RB(high) T cells. We also studied Th2-mediated colitis using mice with disruptions in Muc1 and T-cell receptor α chain (Muc/TCR double knockout mice).
RESULTS: Muc1 deficiency led to the development of more severe forms of Th1- and Th2-induced colitis than controls. Loss of Muc1 increased colonic permeability and the Th17-cell, but not Th2 or Th1 cell, response in the inflamed colon. Loss of Muc1 also promoted expansion of an innate lymphoid cell population (Lin(-) ckit(-) Thy1(+) Sca1(+)) that produces IL-17. The expansion of Th17 adaptive immune cells and innate lymphoid cells required the commensal microbiota.
CONCLUSIONS: Muc1, which is up-regulated by Th17 signaling, functions in a negative feedback pathway that prevents an excessive Th17 cell response in inflamed colons of mice. Disruption of this negative feedback pathway, perhaps by variants in Muc1, might contribute to inflammatory bowel disease in patients.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22202458      PMCID: PMC3441148          DOI: 10.1053/j.gastro.2011.12.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  45 in total

Review 1.  Colitis in transgenic and knockout animals as models of human inflammatory bowel disease.

Authors:  A K Bhan; E Mizoguchi; R N Smith; A Mizoguchi
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

2.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

3.  Duodenal helminth infection alters barrier function of the colonic epithelium via adaptive immune activation.

Authors:  Chien-wen Su; Yue Cao; Jess Kaplan; Mei Zhang; Wanglin Li; Michelle Conroy; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

Review 4.  Mucins and inflammatory bowel disease.

Authors:  T Shirazi; R J Longman; A P Corfield; C S Probert
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

5.  Peripheral lymphoid development and function in TCR mutant mice.

Authors:  P Mombaerts; E Mizoguchi; H G Ljunggren; J Iacomini; H Ishikawa; L Wang; M J Grusby; L H Glimcher; H J Winn; A K Bhan
Journal:  Int Immunol       Date:  1994-07       Impact factor: 4.823

6.  Anti-interleukin-12 antibody for active Crohn's disease.

Authors:  Peter J Mannon; Ivan J Fuss; Lloyd Mayer; Charles O Elson; William J Sandborn; Daniel Present; Ben Dolin; Nancy Goodman; Catherine Groden; Ronald L Hornung; Martha Quezado; Zhiqiong Yang; Markus F Neurath; Jochen Salfeld; Geertruida M Veldman; Ullrich Schwertschlag; Warren Strober
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

7.  Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice.

Authors:  E Mizoguchi; A Mizoguchi; A K Bhan
Journal:  Lab Invest       Date:  1997-03       Impact factor: 5.662

8.  Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus.

Authors:  R R Parmley; S J Gendler
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

9.  Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice.

Authors:  H Iijima; I Takahashi; D Kishi; J K Kim; S Kawano; M Hori; H Kiyono
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

10.  Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.

Authors:  A Mizoguchi; E Mizoguchi; C Chiba; G M Spiekermann; S Tonegawa; C Nagler-Anderson; A K Bhan
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Role of interleukin-22 in inflammatory bowel disease.

Authors:  Lin-Jing Li; Chen Gong; Mei-Hua Zhao; Bai-Sui Feng
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 2.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 3.  MUC1 (CD227): a multi-tasked molecule.

Authors:  Vasso Apostolopoulos; Lily Stojanovska; Sharron E Gargosky
Journal:  Cell Mol Life Sci       Date:  2015-08-21       Impact factor: 9.261

4.  Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities.

Authors:  Lei Yu; Feng-Jie Wang; Yan-Fang Cui; Dong Li; Wen-Rong Yao; Gui-Bo Yang
Journal:  Immunology       Date:  2018-03-09       Impact factor: 7.397

5.  Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.

Authors:  Yoshihiko Sugitani; Atsushi Nishida; Osamu Inatomi; Masashi Ohno; Takayuki Imai; Masahiro Kawahara; Kenichiro Kitamura; Akira Andoh
Journal:  J Gastroenterol       Date:  2020-01-08       Impact factor: 7.527

Review 6.  Healing of intestinal inflammation by IL-22.

Authors:  Atsushi Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2012-02-22       Impact factor: 5.325

7.  Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells.

Authors:  Tze Wei Poh; Cathy S Madsen; Jessica E Gorman; Ronald J Marler; Jonathan A Leighton; Peter A Cohen; Sandra J Gendler
Journal:  Clin Cancer Res       Date:  2013-07-19       Impact factor: 12.531

8.  Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.

Authors:  Jui-Hung Yen; Shuyun Xu; Yong Sung Park; Doina Ganea; Kwang Chul Kim
Journal:  Brain Behav Immun       Date:  2012-12-20       Impact factor: 7.217

9.  Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells.

Authors:  Atsushi Nishida; Kiyotaka Nagahama; Hirotsugu Imaeda; Atsuhiro Ogawa; Cindy W Lau; Taku Kobayashi; Tadakazu Hisamatsu; Frederic I Preffer; Emiko Mizoguchi; Hiroki Ikeuchi; Toshifumi Hibi; Minoru Fukuda; Akira Andoh; Richard S Blumberg; Atsushi Mizoguchi
Journal:  J Exp Med       Date:  2012-12-03       Impact factor: 14.307

Review 10.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.